|
Transplant Statistics: Annual Report : Reference Tables
| Year of Transplant | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | ||
| Functioning Graft at Discharge | 32 | 41 | 34 | 36 | 46 | 67 | 75 | 124 | 120 | 152 | |
| With Immunosuppression Info | 31 | 39 | 34 | 34 | 43 | 66 | 67 | 106 | 83 | 105 | |
| Corticosteroids | Category Usage | 0.0% | 7.7% | 38.2% | 17.6% | 81.4% | 95.5% | 97.0% | 80.2% | 94.0% | 86.7% |
| Prednisone | 0.0% | 5.1% | 38.2% | 11.8% | 76.7% | 84.8% | 85.1% | 75.5% | 88.0% | 76.2% | |
| Methylprednisolone | 0.0% | 2.6% | 0.0% | 5.9% | 9.3% | 15.2% | 16.4% | 9.4% | 8.4% | 12.4% | |
| Cyclosporine | Category Usage | 93.5% | 87.2% | 55.9% | 29.4% | 16.3% | 9.1% | 6.0% | 2.8% | 6.0% | 4.8% |
| Cyclosporin | 93.5% | 87.2% | 55.9% | 29.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Sandimmmune | 0.0% | 0.0% | 0.0% | 0.0% | 2.3% | 4.5% | 1.5% | 0.0% | 0.0% | 1.9% | |
| Neoral | 0.0% | 0.0% | 0.0% | 0.0% | 14.0% | 4.5% | 4.5% | 2.8% | 6.0% | 2.9% | |
| Tacrolimus | Category Usage | 6.5% | 10.3% | 47.1% | 58.8% | 81.4% | 84.8% | 92.5% | 94.3% | 89.2% | 92.4% |
| FK506 | 6.5% | 10.3% | 47.1% | 58.8% | 81.4% | 84.8% | 92.5% | 94.3% | 89.2% | 92.4% | |
| Antimetabolites | Category Usage | 93.5% | 87.2% | 100.0% | 79.4% | 93.0% | 93.9% | 86.6% | 72.6% | 79.5% | 68.6% |
| Azathioprine | 93.5% | 87.2% | 100.0% | 61.8% | 14.0% | 4.5% | 6.0% | 0.0% | 2.4% | 1.0% | |
| Mycophenolate mofetil | 0.0% | 0.0% | 0.0% | 17.6% | 79.1% | 89.4% | 83.6% | 72.6% | 77.1% | 67.6% | |
| Other | Category Usage | 0.0% | 0.0% | 0.0% | 2.9% | 2.3% | 0.0% | 1.5% | 1.9% | 12.0% | 12.4% |
| Rapamycin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.9% | 12.0% | 12.4% | |
| Cytoxan | 0.0% | 0.0% | 0.0% | 2.9% | 2.3% | 0.0% | 1.5% | 0.0% | 0.0% | 0.0% | |
Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline
Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map
SRTR Site designed and maintained by Diamond Bullet Design & URREA.